Supreme Court overturns Limelight and Nautilus cases
02-06-2014
US Supreme Court agrees to hear Nautilus heart monitor case
14-01-2014
Michael Fedorak / Shutterstock.com
A US appeals court has reversed a decision to award $30 million in supplemental damages to The Dow Chemical Company after finding that its patents were invalid under a standard established by the US Supreme Court’s Nautilus v Biosig ruling.
If you have already subscribed please login.
If you have any technical issues please email tech support.
CAFC; The Dow Chemical Company; Nova Chemicals; indefinite claims; US Supreme Court; Nautilus; Biosig; patents
